BioPharma Resources

Drug Trial Radar · NCT02716246

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH for Mucopolysaccharidosis (MPS) IIIA

Last checked: Nov 19, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

36

Planned (sponsor's estimate)

Start

Apr 25, 2016

Primary completion

Mar 2029

Study completion Mar 2029

Sponsor

Lead sponsor
Ultragenyx Pharmaceutical IncIndustry
Sponsor type
Industry
Collaborators
Abeona Therapeutics, Inc
First posted
Mar 23, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective of this study is to evaluate the efficacy and safety of UX111 for the treatment of MPS IIIA.

Conditions

  • MPS IIIA
  • Sanfilippo Syndrome
  • Sanfilippo A
  • Mucopolysaccharidosis III

Interventions

  • UX111Biological

    Self-complementary adeno-associated virus serotype 9 carrying the human SGSH gene under the control of a U1a promoter (scAAV9.U1a.hSGSH) will be delivered one time through a venous catheter inserted into a peripheral limb vein.

  • Prophylactic Immunomodulatory (IM) TherapyDrug

  • Optimized Prophylactic IM TherapyDrug

  • Adjuvant IM TherapyDrug

    The Principal Investigator and/or caregiver, in consultation with the medical monitor, will determine whether to initiate adjuvant IM therapy. Not all participants may receive adjuvant IM therapy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cerebrospinal Fluid (CSF) Heparan Sulfate (HS) (Disaccharide) ExposureTime frame: Up to Month 24 Visit

Locations

5 sites in 3 countries. Site status is shown where the registry gives one.

  • Nationwide Children's Hospital

    Columbus, Ohio · Completed

  • Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania · Completed

  • Women's and Children's Hospital

    North Adelaide, South Australia, Australia · Completed

  • Hospital Clínico Universitario de Santiago

    Santiago de Compostela, Spain · Recruiting

  • Vall d'Hebron Barcelona Hospital Campus

    Barcelona, Barcelona, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.